V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310005341 | 310002458 | 1.62 | 63 | Disease modification (D) | 2018-04-24 | 2018-05-01 | THALIDOMIDE | N | N | 310012247 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 310005342 | 310002458 | 1.66 | 80.3 | Adjuvant (A) | 2018-05-27 | 2018-06-04 | IVE | 2 | N | 310012247 | ICON8B TRIAL |
| 310005343 | 310002459 | 1.69 | 68.6 | Neo-adjuvant (N) | null | 2016-11-10 | BEP 5 Day | N | N | 310012353 | ECHELON 1 TRIAL |
| 310005344 | 310002460 | 1.63 | 91.4 | null | null | 2015-01-07 | CARBOPLATIN + VINORELBINE | N | null | 310012615 | CYCLOPHOSPHAMIDE + LENALIDOMIDE |
| 310005345 | 310002461 | null | 69.5 | Palliative (P) | 2018-12-20 | 2018-12-20 | CVP | N | N | 310012663 | IVE |
| 310005346 | 310002462 | 1.62 | 90 | Neo-adjuvant (N) | null | 2018-05-20 | IVE | N | null | 310012665 | FEC |
| 310005347 | 310002463 | 1.69 | 78.8 | Palliative (P) | 2016-01-12 | 2016-01-16 | Bevacizumab 15mg/kg | N | null | 310012692 | MELPHALAN |
| 310005348 | 310002464 | 1.78 | 145 | Palliative (P) | 2018-02-17 | 2018-02-18 | Brentuximab | N | N | 310012726 | DABRAFENIB + TRAMETINIB |
| 310005349 | 310002465 | 1.78 | 70.5 | Neo-adjuvant (N) | 2018-06-23 | 2018-06-23 | POUT TRIAL | N | N | 310012759 | DABRAFENIB |
| 310005350 | 310002465 | 1.64 | 56.4 | Palliative (P) | 2017-04-18 | 2017-04-22 | IVE | 2 | N | 310012759 | OLAPARIB |
| 310005351 | 310002466 | 1.67 | 61.8 | Palliative (P) | 2016-05-03 | 2016-05-04 | Everolimus 10mg | 01 | N | 310012971 | GDP |
| 310005352 | 310002466 | 1.63 | 52 | Palliative (P) | null | 2015-02-23 | FEC 100 | null | null | 310012971 | METHOTREXATE HIGH DOSE |
| 310005353 | 310009273 | 1.73 | 87.7 | Palliative (P) | 2016-07-14 | 2016-07-15 | Cisplatin + Pemetrexed | N | N | 310012991 | AXITINIB |
| 310005354 | 310009273 | 1.74 | 48.75 | Palliative (P) | 2016-02-03 | 2016-09-09 | BEP 5 Day | 02 | N | 310012991 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 310005355 | 310002467 | 1.59 | 71.4 | Curative (C) | 2015-07-07 | 2015-07-28 | Bevacizumab+Carbo+Gemcitabine | N | N | 310013033 | CARBOPLATIN + LIPOSOMAL DOX |
| 310005356 | 310002468 | 1.6 | null | Curative (C) | 2017-02-11 | 2017-07-06 | DABRAFENIB + TRAMETINIB | 02 | N | 310013066 | METHOTREXATE |
| 310005357 | 310002468 | null | 0 | Palliative (P) | 2017-04-05 | 2017-04-07 | BEP 5 Day | N | N | 310013066 | CARBOPLATIN + DOCETAXEL |
| 310005358 | 310009274 | 0 | 64.8 | Palliative (P) | 2017-03-27 | 2017-04-09 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | 310013071 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 310005359 | 310010454 | null | 77.9 | Palliative (P) | 2014-07-20 | 2014-07-20 | NIVOLUMAB | null | N | 310013090 | BRENTUXIMAB |
| 310005360 | 310010454 | 1.88 | 54 | Curative (C) | 2017-09-01 | 2017-09-03 | CAPECITABINE + CARBOPLATIN | N | null | 310013090 | ATEZOLIZUMAB |
| 310005361 | 310002469 | 1.86 | 67.6 | Neo-adjuvant (N) | 2014-04-28 | 2014-05-05 | DABRAFENIB | 02 | null | 310013139 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 310005362 | 310002470 | null | 76.3 | Palliative (P) | 2017-12-31 | 2017-12-31 | Temozolomide + RT | N | N | 310013145 | CYTARABINE |
| 310005363 | 310002470 | 1.76 | 87.6 | Palliative (P) | 2015-03-26 | 2015-04-02 | Bendamustine+Rituximab(Sub Courses) | N | N | 310013145 | SELPAC TRIAL |
| 310005364 | 310002471 | 0 | 92.7 | Neo-adjuvant (N) | 2014-04-20 | 2014-03-20 | Enzalutamide | 2 | Y | 310013253 | IRINOTECAN + TEMOZOLOMIDE |
| 310005365 | 310002472 | 1.63 | 55 | Curative (C) | 2015-05-25 | 2015-06-13 | Olaparib | Y | N | 310013273 | DHAP |
| 310005366 | 310007024 | 1.76 | null | Palliative (P) | null | 2015-03-22 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 2 | N | 310013310 | ABVD |
| 310005367 | 310002473 | 1.6 | null | Palliative (P) | 2015-09-19 | 2016-08-20 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 2 | N | 310013374 | CISPLATIN + FLUOROURACIL + RT |
| 310005368 | 310002474 | 1.33 | 90.95 | null | 2015-10-13 | 2015-10-15 | Gemcitabine + Oxaliplatin | N | N | 310013466 | CYCLOPHOSPHAMIDE + ETOPOSIDE + LOMUSTINE |
| 310005369 | 310002474 | 1.56 | 67.2 | Adjuvant (A) | 2018-09-22 | 2018-09-29 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | 310013466 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310005370 | 310002475 | 1.57 | 52 | Adjuvant (A) | 2014-08-16 | 2014-08-16 | OCTREOTIDE | null | N | 310013547 | CYCLOPHOSPHAMIDE + DOCETAXEL |
| 310005371 | 310002476 | 1.67 | null | Curative (C) | 2016-05-13 | 2016-05-14 | Carboplatin + Vinorelbine Oral | 02 | null | 310013634 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310005372 | 310002477 | 1.52 | 88 | Palliative (P) | 2016-11-29 | 2016-12-01 | AC | N | N | 310013660 | THALIDOMIDE |
| 310005373 | 310007026 | 1.73 | null | Palliative (P) | 2017-08-02 | 2017-08-04 | Doxorubicin + Olaratumab | 2 | N | 310013677 | CAPECITABINE + CISPLATIN + RT |
| 310005374 | 310002478 | 1.64 | 63.7 | Curative (C) | 2017-04-04 | 2017-04-27 | IVE + METHOTREXATE | N | Y | 310013706 | CAPECITABINE + CARBOPLATIN |
| 310005375 | 310007027 | 1.75 | null | Palliative (P) | 2014-11-08 | 2014-11-08 | Carboplatin+Fluorouracil 4 or 5 day | 2 | N | 310013748 | DABRAFENIB + TRAMETINIB |
| 310005376 | 310002479 | 1.73 | 135 | Palliative (P) | 2016-07-22 | 2016-07-31 | CISPLATIN + VINORELBINE + RT | N | N | 310013847 | UKALL2011 |
| 310005377 | 310002480 | null | 68.6 | Curative (C) | 2016-08-29 | 2016-09-01 | Carboplatin + Vinorelbine Oral | Y | N | 310013946 | BEVACIZUMAB + IRINOTECAN + MDG |
| 310005378 | 310002481 | 1.55 | 59 | Adjuvant (A) | 2018-04-14 | 2018-04-17 | Bevacizumab+Carbo+Gemcitabine | 02 | N | 310014050 | CHLORAMBUCIL + ETOPOSIDE + LOMUSTINE |
| 310005379 | 310002482 | null | 90.3 | null | 2018-05-09 | 2018-05-09 | MITOMYCIN | 02 | null | 310014077 | IFOSFAMIDE + PACLITAXEL |
| 310005380 | 310007028 | 1.85 | 76.4 | Palliative (P) | 2018-05-18 | 2018-05-18 | Sunitinib | N | N | 310014114 | CISPLATIN + FLUOROURACIL + RT |
| 310005381 | 310007028 | null | null | Palliative (P) | null | 2018-11-19 | IVE | null | null | 310014114 | SUNITINIB |
| 310005382 | 310007028 | 1.83 | 97 | Palliative (P) | 2017-03-12 | 2017-04-01 | DABRAFENIB + TRAMETINIB | 2 | N | 310014114 | INTERFERON |
| 310005383 | 310002483 | 1.74 | 74.7 | null | 2018-01-20 | 2018-02-10 | Bendamustine+Rituximab (1st Course) | 02 | N | 310014240 | DABRAFENIB + TRAMETINIB |
| 310005384 | 310002484 | null | null | Curative (C) | 2017-01-02 | 2017-01-05 | CARBOPLATIN + VINORELBINE | N | N | 310014276 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN |
| 310005385 | 310002484 | 1.8 | 82.5 | Palliative (P) | 2017-10-14 | 2017-10-15 | CARBOPLATIN + RT | N | N | 310014276 | HCX |
| 310005386 | 310002485 | 1.61 | null | Palliative (P) | 2018-02-09 | 2018-02-10 | EC | Y | N | 310014395 | OCTREOTIDE |
| 310005387 | 310002486 | 1.54 | 69.7 | Palliative (P) | 2017-01-01 | 2017-01-05 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + VINCRISTINE | 02 | N | 310014403 | CYCLOPHOSPHAMIDE + GEMCITABINE + VINCRISTINE |
| 310005388 | 310002487 | 1.69 | 79.8 | Palliative (P) | 2016-10-11 | 2016-10-22 | DABRAFENIB | N | N | 310014496 | CVP R |
| 310005389 | 310002487 | null | 77.7 | Neo-adjuvant (N) | 2017-09-28 | 2017-10-01 | CYCLOPHOSPHAMIDE + ETOPOSIDE + LOMUSTINE | 02 | null | 310014496 | PCV |
| 310005390 | 310002488 | 1.8 | 0 | Adjuvant (A) | 2018-06-28 | 2018-07-07 | Chlorambucil | Y | N | 310014644 | ENZALUTAMIDE |